Cargando…
lincRNA-p21 inhibits the progression of non-small cell lung cancer via targeting miR-17-5p
Non-small-cell lung cancer (NSCLC) is well established as one of the major subtypes of human lung cancer. NSCLC is characterized by a high incidence rate and poor patient prognosis. Previous studies have identified that long intergenic non-coding RNA (lincRNA) serves a key role in the development of...
Autores principales: | Ao, Xiang, Jiang, Ming, Zhou, Jie, Liang, Hongling, Xia, Haoming, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312999/ https://www.ncbi.nlm.nih.gov/pubmed/30535441 http://dx.doi.org/10.3892/or.2018.6900 |
Ejemplares similares
-
LincRNA-p21: Implications in Human Diseases
por: Tang, Sai-Sai, et al.
Publicado: (2015) -
Orchestration of lincRNA-p21 and miR-155 in Modulating the Adaptive Dynamics of HIF-1α
por: Sun, Cheng-Yuan, et al.
Publicado: (2020) -
LincRNA‐p21 alleviates atherosclerosis progression through regulating the miR‐221/SIRT1/Pcsk9 axis
por: Wang, Haojie, et al.
Publicado: (2021) -
Identification of a Novel lincRNA-p21-miR-181b-PTEN Signaling Cascade in Liver Fibrosis
por: Yu, Fujun, et al.
Publicado: (2016) -
Decreased FENDRR and LincRNA-p21 expression in atherosclerotic plaque
por: Çekin, Nilgün, et al.
Publicado: (2018)